Weak acid-initiated slow release of Dexamethasone from hydrogel to treat orbital inflammation

Rationale: Orbital inflammation is a prevalent and prolonged ocular disease that poses a significant challenge to clinicians. Glucocorticoid Dexamethasone sodium phosphate (Dex) has demonstrated efficacy in the clinical treatment of nonspecific orbital inflammation. However, frequent administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinjing, Zhang, Aichi, Zhao, Andi, Chen, Zhaoxia, Liang, Gaolin, Liu, Hu, Wu, Chengfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405854/
https://www.ncbi.nlm.nih.gov/pubmed/37554273
http://dx.doi.org/10.7150/thno.85627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405854/
https://www.ncbi.nlm.nih.gov/pubmed/37554273
http://dx.doi.org/10.7150/thno.85627

Ejemplares similares